Warner Bros. Discovery-Paramount merger antitrust trial set for 2027, with state lawsuit from Bonta moving forward

A court has scheduled an antitrust trial for 2027 tied to the proposed merger of Warner Bros. Discovery and Paramount, according to a report published this week. The trial is expected to run for 12 court days, putting a concrete timetable on a lawsuit that has been moving through the legal system rather than remaining in pretrial uncertainty.

The report says California Attorney General Rob Bonta’s case is continuing to move forward, indicating that at least one major strand of the antitrust challenge will be litigated on the merits rather than resolved solely through motions or settlement talks.

For Warner Bros. Discovery, the timing matters because large media deals typically require both regulatory approvals and legal clarity before companies can finalize transactions that involve network, streaming, and studio assets. Even when the parties continue to argue for the strategic rationale of a combination, courts can still become the pacing item for when (or whether) deal closing can occur.

The scheduled trial also reinforces how antitrust enforcement in the media sector increasingly focuses on whether consolidation could harm competition in distribution, advertising, or content markets. While the report does not detail the specific legal theories to be tested in court, a trial setting implies that the dispute will likely turn on evidence and arguments that go beyond broad policy statements.

In practical terms, a 12-day schedule suggests the proceeding may be concentrated, with parties presenting selected witnesses, documents, and expert material rather than a long, open-ended courtroom fight. The report does not specify who will testify or what remedies may be sought, but setting a defined trial window is typically a announcement that judges are preparing for an adjudication that can materially affect the transaction path.

For the market, the main near-term implication is that uncertainty around the deal will persist into the next year’s calendar planning and could keep analysts and investors focused on regulatory and litigation milestones instead of only on operating performance. The existence of a trial date can also reduce the odds of a quick resolution, though it does not rule out later settlement discussions.

Another implication is that any additional rulings leading up to 2027 could become decisive. Pretrial decisions on discovery, admissibility of evidence, or the scope of claims often shape how a company assesses risk, even before the first day of testimony.

For now, the publicly reported information remains limited. The report does not provide details on what filings were accepted, what stage the court has reached in the California case, or whether other regulatory proceedings and lawsuits are moving in parallel. Watch for further court filings, legal briefs, or official statements that describe the specific issues the parties will argue at trial, as well as any changes to the schedule.